A carregar...
Naltrexone/Bupropion extended release‐induced weight loss is independent of nausea in subjects without diabetes
Naltrexone/bupropion extended release (NB) is indicated as an adjunct to a reduced‐calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of ≥30 or ≥27 kg m(−2) and ≥1 weight‐related comorbidity (e.g. hypertension, type 2 diabetes and dys...
Na minha lista:
| Publicado no: | Clin Obes |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5129540/ https://ncbi.nlm.nih.gov/pubmed/27477337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cob.12157 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|